ANIMATION

Curosurf Intratracheal Suspension

Share this animation:

Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, which may result in atelectesis. Curosurf (poractant alfa) is an intratracheal surfactant suspension indicated for the rescue treatment of premature infants suffering from RDS.

Share It:
Contact XVIVO

Client


Cornerstone Therapeutics

XVIVOs staff of consummate professionals worked seamlessly and flawlessly; adding valuable creative input, maintaining perfect communication, meeting or beating the timeline, and coming in within budget. If you want the absolute best in the field, look no further. Give Robert Krensel a call right away. Or you can just take your chances.

VP, Associate Creative Director, Revolution Health
Share this animation: